South Carolina Life Sciences Conference Expects Record Gathering

GREENVILLE, S.C. - Nov. 14, 2022 - PRLog -- With the COVID-19 pandemic receding and America's economy surging, the largest life sciences conference in Palmetto State history will convene February 21-23 in Charleston.

Themed "Tomorrow Starts Here," the 2-day SCBIO 2023 event will feature national speaker sessions on Winning the War on Cancer, Made in SC:  Innovation at Home, Transforming Healthcare Digitally, and Reshoring/Onshoring among over 20 sessions – all topics driving the state's fastest growing industry: life sciences.

A $25.7 billion annual industry here growing faster than in any other Southeastern state, conference speakers include national pharma and medtech executives, economic developers, leaders from South Carolina's research universities, healthcare executives, business and financial industry officials, national media and many others.  In all, over 30 speakers will present a plethora of topical choices to attendees at the conference, now recognized as among life sciences' finest across the entire region.

Full details are available online at https://www.scbio.org, and registration to attend the 2-day conference is now open.  Registration and exhibiting are free or discounted to SCBIO investors, and the conference is open to the public.

"Life sciences is a key driver of South Carolina's economy, and this conference's growth is testament to the industry's surging impact, reach and rapidly rising economic significance in our state," stated Mike Brenan, South Carolina regional president for Truist and the 2023 Conference Chair.  "Already accounting for over 85,000 highly-skilled jobs in the Palmetto State, life sciences have tremendous growth potential, and we're excited to showcase the top companies, leaders, research universities and support organizations from across our state and country at SCBIO 2023."

The 2-day conference annually draws attendees from across America for networking, innovation updates, opportunity discovery, partnership making and strategic discussion. Already committed attendees include officials across a broad spectrum of life sciences industries including medical devices, bio manufacturing, drug discovery, R&D, pharmaceuticals, diagnostics and testing, digital health and health IT, bio-ag and more.

SCBIO is South Carolina's investor-driven economic development organization exclusively focused on building, advancing, and growing the life sciences industry in the state. The industry has more than 1,000 firms directly involved in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental, and agricultural biotechnology products.

Among leading biotech and med-tech industry brands participating in the conference are Nephron Nitrile, Nephron Pharmaceuticals, Bristol Myers Squibb, BIO, Johnson & Johnson, AVX, PhRMA, Medpoint, AdvaMed, Poly-Med, VWR, Rhythmlink, C-Safe, ZEUS, Patheon Thermo Fisher, Zverse, Abbott, Alcami and more. All of South Carolina's research universities – MUSC, Clemson and the University of South Carolina – are represented, as are major healthcare systems, and economic development entities including the South Carolina Department of Commerce, SCRA, South Carolina Hospital Association and others.